{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (1S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-17-propyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
| image = Rosterolone.svg
| width = 250

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Topical administration|Topical]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 79243-67-7
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 71232
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 64367
| UNII = 3L5C5C8ZNG
| ChEMBL = 2107498

<!--Chemical data-->
| C=23 | H=38 | O=2
| molecular_weight = 346.54662 g/mol
| smiles = CCCC1(CCC2C1(CCC3C2CCC4C3(C(CC(=O)C4)C)C)C)O
| StdInChI_Ref = 
| StdInChI = 1S/C23H38O2/c1-5-10-23(25)12-9-19-18-7-6-16-14-17(24)13-15(2)22(16,4)20(18)8-11-21(19,23)3/h15-16,18-20,25H,5-14H2,1-4H3/t15-,16-,18-,19-,20-,21-,22-,23-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = IMFNBOMNWHWKQD-MXENSADDSA-N
| synonyms = 17α-Propylmesterolone; 17β-Hydroxy-1α-methyl-17α-propyl-5α-androstan-3-one
}}
{{Distinguish|rotenolone}}
'''Rosterolone''' ([[International Nonproprietary Name|INN]]) (developmental code name '''SH-434'''), also known as '''17α-propylmesterolone''' or '''1α-methyl-17α-propyl-5α-androstan-17β-ol-3-one''', is a [[steroid]]al [[antiandrogen]] that was first reported in 1984 and was developed for [[topical administration]] but was never marketed.<ref name="LuderschmidtEiermann1984">{{cite journal|last1=Luderschmidt|first1=Christoph|last2=Eiermann|first2=Wolfgang|last3=Jawny|first3=Johannes|last4=Bidlingmaier|first4=Frank|last5=Ring|first5=Johannes|title=17?-Propylmesterolone (SH 434): an antiandrogenic sebosuppressive substance not influencing circulating testosterone concentrations|journal=Naunyn-Schmiedeberg's Archives of Pharmacology|volume=328|issue=2|year=1984|pages=214–218|issn=0028-1298|doi=10.1007/BF00512076}}</ref><ref name="SinghGauthier2000">{{cite journal|last1=Singh|first1=Shankar|last2=Gauthier|first2=Sylvain|last3=Labrie|first3=Fernand|title=Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships|journal=Current Medicinal Chemistry|volume=7|issue=2|year=2000|pages=211–247|issn=0929-8673|doi=10.2174/0929867003375371|pmid=10637363}}</ref><ref name="LuderschmidtEiermann1984">{{cite journal|last1=Luderschmidt|first1=Christoph|last2=Eiermann|first2=Wolfgang|last3=Jawny|first3=Johannes|last4=Bidlingmaier|first4=Frank|last5=Ring|first5=Johannes|title=17?-Propylmesterolone (SH 434): an antiandrogenic sebosuppressive substance not influencing circulating testosterone concentrations|journal=Naunyn-Schmiedeberg's Archives of Pharmacology|volume=328|issue=2|year=1984|pages=214–218|issn=0028-1298|doi=10.1007/BF00512076}}</ref> It has shown some [[efficacy]] in the treatment of [[acne]], and in [[animal model]]s lacks systemic effects with topical application.<ref name="LuderschmidtEiermann1984" /><ref name="SinghGauthier2000" /> Rosterolone is a derivative of [[mesterolone]], which, in contrast, is an [[androgen]] and [[anabolic steroid]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA775|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=775–}}</ref>

==See also==
* [[Steroidal antiandrogen]]
* [[List of steroidal antiandrogens]]

==References==
{{Reflist|2}}


{{Androgen receptor modulators}}

[[Category:Androstanes]]
[[Category:Anti-acne preparations]]
[[Category:Antiandrogens]]


{{steroid-stub}}
{{dermatologic-drug-stub}}